> Ǿ > ž  

					
  ű ǰ ǰ ǰ : DBMN100, DH-SQP, DARGN600J  ۼ

					

					

HL 20-12

ǰ

ű ǰ ǰ ˷帮 ῡ Ͻñ ٶϴ.

 

395. ȿ

Bromelain

DBMN100 100mg/Tab Brodase(dz) Ϲ(395)

[] ϴ νŸ۶ ռ ϰ ۿ Ÿ ҽŴ.

[ȿ] (α) ȭ, ܻ Ǵ (α).

[] 12 ̻ Ҿ : 1, 1 2ȸ, 30п .

[] ι, , .

[ݱ] ̻(), ȯ, ȯ, Ǵ ȯ, Ӻ, , 12 ̸ Ҿ, ҳ.

[] ׻(ƮŬ ) ۿ . м Ұ(, DUR Ǿǰ).

[Ӻ] Ȯ(ݱ).  

 

396.

Soliquapen (10-40) inj.

DH-SQP 1Pen(3ml) Insulin Glargine(recombinant) 10.9134mg(Human Insulin 300IU), Lixisenatide 0.15mg(ǾƺƼ) (396)

[] ν insulin glargine() ܽð GLP-1 ü ȿ lixisenatide (̾) ν , GLP-1 ü ȿ .

[ȿ] 2 索 ȯ Ű Ʈΰ ٸ 汸 簭 ȿ Ʈΰ , ν ܵ ȿ ܵ , ν Ʈ Ʈΰ .

[] 1 1ȸ, Ļ 1ð ̳ ȯ ν ʿ䷮(10~40) , , ο SC. ģ Ļ 1ð ̳ . 뷮 ν ۶ ϸ, 1 insulin glargine 1IU lixisenatide 0.5g . ġ ν ̰ڳ insulin glargine 20IU ̸ ȯڴ 10 , ν ۶ 20~30IU ȯڴ 20 (Ÿ ν(1 2ȸ ν, ν ۶(300IU/ml, )) ȯ 120% Ͽ ). ٰŷ ν ۶ 뷮 (Max. 40IU/20g/Day).

[] , , , , , εο, , ε巯, , ȭҷ, , Ƿ, ֻ .

[ݱ] ࿡ ι ִ ȯ, 1, 索 ȯ.

[] , ޼ 忰, ȯ, ű . ȿ 汸 Ǿǰ ҽų Ƿ, ׻ ؿ ΰ ּ 1ð , Ǵ 4ð Ŀ . ˷ (Ÿũ ). ٸ ν ȥϰų . (28), ǿ(30C ) ϸ, 14 ̳ .

[Ӻ] Ӻαݱ 2.

 

399. з ʴ 缺 Ǿǰ

L-arginine hydrochloride

DARGN600J 15g/25ml Vial GC Arginine() (399) ޿

[] ȸο ƾ ü ۿϿ ϸϾ . L-Ƹκ ȭ ռ. ϼü Ҹ佺Ÿƾ ۿ Ͽ ȣ к .

[ȿ] õ ȸ ̻(CPS(Carbamyl phosphate synthetase) , OTC(Ornitine transcarbamylase) , ASS(Arginosuccinate synthetase) , ASL(Arginosuccinate lyase) ), ܹ ҳ ϸϾ ޼ ȭ 汸 Ұ ϸϾƳ . 缺Į 꼺ȭ. ȣ к ϼü ɰ˻(ν Ǵ ̿, ̿ ˻縸 ).

[] ϸϾ : 0.2~1g/kg, 1ð ̻ IV infusion. 缺Į : ϰ ϴ ź꿰 ҷ(mM/L) [ȯ ü(kg)/9.6]. ȣ к : 500mg/kg 10% Ͽ 30 ̻ IV infusion. [ܹ] ݽ ħ, Ǵ ٸ ƿ 30а ֻ ϸ, ݴ ƿ 30 , 0, 30, 60, 90, 120, 150 ä. 鿪 ä ɺиϰ 20 . ȣ Ǵ ν (1 ).

[] , , ȫ, , , , Ƴʶ , ˷ , Į, , ε巯.

[ݱ] ˷ Ͼ ȯ, , , , ȭ õ ȯ, ɱٰ, ƸѺȿ ȯ.

[] , ߵ , ȯ Ǵ , , ұ ȯ, õȯ. Ƿγ (Į ). ܺη Ǻα, ˾ . ּ 100ml ̻ (NS ) .

[Ӻ] FDA B.

 

439. Ÿ ġ

Ranibizumab

DRBIMBF 1.65mg/0.165ml PFS Lucentis PFS(Ƽ) (439)

[] VEGF-A(vascular endothelial growth factor A) Ȱ Ͽ VEGF-A ϰ VEGF-A ο ҽŴ.

[ȿ] Ż() ɰ Ȳݺ ġ. 索 Ȳݺ, ⼺ Ȳݺ, ƶ Ż ÷ ջ ġ.

[] 0.5mg(0.05ml), 1 ̻ ü . ɰ, 索 Ȳݺ : Ȱ . ⼺ Ȳݺ : 3ȸ ÷ , ٽ ÷ ջ Ÿ . ƶ Ż : 1ȸ , Ȱ ÷Ͽ ġ . Ͽ 30G1/2ġ ֻħ ̿, ֻٴ 漱 ϸ鼭 ȱ ߽ ڷ 3.5~4.0mm ü . ݺ ü ֻ ʰ .

[] ȱ, ڸ, , μ ܻ 鳻, , , ȱ, ü, , üڸ, ȱڱ, ̹, þ, Ǯ, ȱ, ȱ, ü, к, ȱҾ, , , ȳ , , ȱ谨, , ijȥŹ, , Ǽи, , , һǿ, ÷ , ü, ü, , ȫä, ȫäü, , ع鳻, , , , ÷帲, ֻ , ȱ, ȱк, , ν, Ǯ, ȱ, ħ, , ˷ , ÷翣, , , Ҿ.

[ݱ] , ȱ Ǵ ȱ ֺ ְų ǽɵǴ ȯ, ȳ ִ ȯ.

[] 1 1ȸ ü ֻ, ֻ . Ⱦ, ýŰ ͸, 60 ̳ Ͻ Ⱦ Ÿ . ٸ -VEGF . : ִ ÷(BCVA) ÷ 򰡿 񱳽 30 ǥ ̻ , Ⱦ 30mmHg ̻ , , ߽ɿ͸ , Ǵ ũⰡ ü 50% ̻ , Ȥ 28ϳ ȳ Ͽų ȹ . ġ ߴ : ڸ Ȥ 3 Ǵ 4 Ȳ ߻ . (2~8), ǿº(25) 24ð̳ .

[Ӻ] Ӻαݱ 2.

 

629. Ÿ ȭп

Biktarvy

DBIKTV 1 Bictegravir 50mg(Bictegravir sodium 52.45mg), Emtricitabine 200mg, Tenofovir alafenamide 25mg(Tenofovir alafenamide fumarate 28.04mg)(渮̾) (629)

[] Bictegravir : ױ׷ (INSTI) HIV-1 HIV-2 . Emtricitabine : Ŭõ ȿ (NRTI) HIV1, HIV2, HBV . Tenofovir Alafenamide : ŬƼ ȿ (NtRTI) HIV1, HIV2, HBV .

[ȿ] ׷Ʈι̷ ġ ų, ׷Ʈι̷ ġ ġ  3 ̻ ̷ ġ ȿ ̸(HIV-1 RNA < 50 copies/ml), п ˷ ġȯ HIV-1 ġ.

[] 1 1ȸ 1, Ļ . ð ģ 18ð ̸̳ , ð ̳ 1 ߰ .

[] , , , , , , Ƿ, , ڻ ൿ, Ҿ, , , , ȭҷ, θ, , , , , ε巯, .

[ݱ] ࿡ ȯ, ǽ, ƮƮ, ƿ .

[] C ȯڿ ȿ Ȯ. B ̷ θ Ȯ. HBV ġ(׳ ˶䳪̵, ׳ Ͻ, ̺ε, Ƶ Ǻ) . ٸ ׷Ʈι̷ (HIV-1 ġ) . ׳׽, ˷̴ , ö ּ 2ð Ǵ İ Բ 2ð . Ÿڳ, , īٸ, Ŭν, ī, ٺŻ, , ĺƾ, ƾ, ũƮ . , ü, , ġ ͸ , , 鿪 籸 ı, ȸ , 񱫻 . м Ұ.

[Ӻ] Ȯ. 

 

ű

ڵ

Է

ǰ
(ȸ)

ǽ

DJTMD50

Tramadol HCl 50mg/Cap

Tridol
()

DTMD50 ü

2020.
05.12

DJTMD50-W

DTMD50-W ü

 

ǰ

ڵ

Է

ǰ
(ȸ)

ǽ

DTMD50
(: BTRD)

Tramadol HCl 50mg/Cap

Zipan
(ϼ)

ߴ
ü : DJTMD50



DTMD50-W
(ġ)

ߴ
ü : DJTMD50-W

 

 

2020. 05. 12. 

ǰ ( 9561)